ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,292 | -3.0% | 21,590 | 0.0% | 0.00% | – |
Q2 2023 | $79,667 | +24.5% | 21,590 | +11.4% | 0.00% | – |
Q1 2023 | $64,000 | +30.6% | 19,373 | +51.0% | 0.00% | – |
Q4 2022 | $49,000 | -14.0% | 12,829 | -55.5% | 0.00% | – |
Q2 2022 | $57,000 | +9.6% | 28,833 | 0.0% | 0.00% | – |
Q1 2022 | $52,000 | +116.7% | 28,833 | +55.4% | 0.00% | – |
Q4 2021 | $24,000 | +20.0% | 18,552 | 0.0% | 0.00% | – |
Q3 2021 | $20,000 | -31.0% | 18,552 | 0.0% | 0.00% | – |
Q2 2021 | $29,000 | -12.1% | 18,552 | 0.0% | 0.00% | – |
Q1 2021 | $33,000 | +6.5% | 18,552 | +14.2% | 0.00% | – |
Q4 2020 | $31,000 | +40.9% | 16,242 | +55.4% | 0.00% | – |
Q3 2020 | $22,000 | – | 10,452 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |